Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours
Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg
- Manufacturer
- We Care Distributor Inc. | Elysium Pharmaceutical Ltd.
- Effective date
- 2016-03-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-05-31 22:45:25
Label at a glance#
ProductSENNA-S
Active ingredientSENNOSIDES, DOCUSATE SODIUM
Label structure9 sections
Dosage and administration
take preferably at bedtime or as directed by a doctor ■ adults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day ■ children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day ■ children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day ■ children under 2 ...
Storage and handling
each tablet contains: calcium 21 mg each tablet contains: sodium 3 mg VERY LOW SODIUM store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
Contacts and useful links#
Websitewww.wecaredistributor.com
www.wecaredistributor.com
www.wecaredistributor.comLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active Ingredient (in each tablet) | Purpose |
| Docusate Sodium 50 mg | Stool Softener |
| Sennosides 8.6 mg | Laxative |
Uses
- relieves occasional constipation (irregularity)
- generally produces bowel movement in 6-12 hours
Warnings
Do not use
- if you are now taking mineral oil, unless directed by a doctor
- laxative products for longer than 1 week unless directed by a doctor
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor if
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
take preferably at bedtime or as directed by a doctor
■ adults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day
■ children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day
■ children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day
■ children under 2 years - starting dosage: ask a doctor, maximum dosage: ask a doctor
Other information
- each tablet contains: calcium 21 mg
- each tablet contains: sodium 3 mg VERY LOW SODIUM
- store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
Inactive ingredients
croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide
Questions or comments?
1-888-705-WECARE (Mon-Fri 9am-5pm EST) or www.wecaredistributor.com
PRINCIPAL DISPLAY PANEL
Compare to the Active Ingredients inSenokot-S®
Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg
TO OPEN
PUSH IN TAB AND PULL OUT
25 Pouches of 2 Tablets Each
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70005-016-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7726-f424-e053-dadaa90a57ce | Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg |
| 70005-016-25 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7726-f424-e053-dadaa90a57ce | Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg |
| 70005-016-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7726-f424-e053-dadaa90a57ce | Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70005-016-02 | SENNA-S | 2 in 1 POUCH | TABLET, COATED | 2 | 5 | |
| 70005-016-25 | SENNA-S | 2 in 1 POUCH | TABLET, COATED | 2 | 5 | |
| 70005-016-25 | SENNA-S | 25 in 1 BOX | TABLET, COATED | 25 | 5 | |
| 70005-016-50 | SENNA-S | 2 in 1 POUCH | TABLET, COATED | 2 | 5 | |
| 70005-016-50 | SENNA-S | 50 in 1 BOX | TABLET, COATED | 50 | 5 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- SENNA-S
- Senna and Docusate Sodium Tablets, 8.6 mg
- SENNOSIDES
- DOCUSATE SODIUM
- DOCUSATE
- CROSCARMELLOSE SODIUM
- SILICON DIOXIDE
- CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
- D&C YELLOW NO. 10
- FD&C YELLOW NO. 6
- HYPROMELLOSES
- CELLULOSE, MICROCRYSTALLINE
- MAGNESIUM STEARATE
- MALTODEXTRIN
- POLYETHYLENE GLYCOL 1000
- STEARIC ACID
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70005-016 | 70005-016-25, 70005-016-50, 70005-016-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b2b627ad-deee-4e8e-b2b2-686d97323782 | fd4753fe-f5db-4080-bc32-11508e69d05a | 2016-03-07 | Warnings | b2b627ad-deee-4e8e-b2b2-686d97323782 fd4753fe-f5db-4080-bc32-11508e69d05a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.